American Society of Clinical Oncology

SHERPA: White

People

  1. Kris
    Kris
  2. Miller
    Miller
  3. Heelan
    Heelan
  4. Ladanyi
    Ladanyi
  5. Pfister
    Pfister
  6. Riely
    Riely
  7. Solit
    Solit

Groups

  1. Department of Medicine (4)
  2. Solid Tumor Oncology Division (4)
  3. Thoracic Oncology (4)
  4. GSK Faculty (2)
  5. Human Oncology and Pathogenesis Program (2)
  6. Genitourinary Oncology Service (1)
  7. Head and Neck Service (1)
  8. Nursing (1)
  9. Tow Center for Developmental Oncology (TCDO) (1)
Search Within
  1. "2005"
  2. "Naiyer Rizvi"
Formats
  1. Meeting Abstract (5)
Groups
  1. Department of Medicine (4)
  2. Solid Tumor Oncology Division (4)
  3. Thoracic Oncology (4)
  4. GSK Faculty (2)
  5. Human Oncology and Pathogenesis Program (2)
  6. Genitourinary Oncology Service (1)

More Groups

People
  1. Naiyer Rizvi (5)
  2. Mark Kris (4)
  3. Christopher Azzoli (3)
  4. Jorge Gomez (3)
  5. Vincent Miller (3)
  6. Lee Krug (2)

More People

Years
  1. 2005 (5)
Publications
  1. Journal of Clinical Oncology (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of KOS-862 (epothilone D) as second-line therapy in non-small cell lung cancer
    Meeting Abstract

    Yee, L.; Lynch, T.; Villalona-Calero, M.; Rizvi, N.; Gabrail, N.; Sandler, A.; Cropp, G.; Palmer, G.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Phase I/II trial of gefitinib and RAD001 (everolimus) in patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Milton, D. T.; Kris, M. G.; Azzoli, C. G.; Gomez, J. E.; Heelan, R.; Krug, L. M.; Pao, W.; Pizzo, B.; Rizvi, N. A.; Miller, V. A.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Correlation of EGFR and KRAS mutation status, response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors and survival with histologic subtypes of adenocarcinoma of the lung
    Meeting Abstract

    Hussain, S.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.; Pao, W.; Riely, G.; Rizvi, N.; Gomez, J. E.; Miller, V.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • A phase I dose escalation trial of pulsatile high dose gefitinib and docetaxel in patients with an advanced solid tumor
    Meeting Abstract

    Fury, M. G.; Kris, M.; Solit, D.; Pfister, D. G.; Azzoli, C. G.; Henry, R.; Su, Y. B.; Rizvi, N.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Measurements of total DNA and methylated tumor suppressor genes in the plasma of patients with metastatic non-small cell lung cancer (NSCLC) before, and after chemotherapy, as potential biomarkers for response to treatment
    Meeting Abstract

    Azzoli, C. G.; Park, S.; Gomez, J.; Krug, L.; Miller, V.; Rizvi, N.; Ben-Porat, L.; Danenberg, K.; Danenberg, P.; Kris, M.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save